Sign in to view content

Safety and Efficacy of CRISPR-Based Genome Editing for Neovascular AMD

Glenn C. Yiu, MD, PhD

Video
Published 2023

Related

One-Year Outcome of Intravitreal Ziv-Aflibercept Therapy For Nonresponsive Neovascular Age-Related Macular Degeneration
Jay Chhablani, MD
On Demand Cases, Courses, and Papers
2017
Intravitreal Gene Therapy for Neovascular AMD With ADVM-022: Results of the Phase 1 OPTIC Trial
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2020
Assessing Supplemental Injection Use Across Groups in the Phase 2 DAVIO 2 Trial of EYP-1901 vs Aflibercept in Wet Age-Related Macular Degeneration
Veeral S. Sheth, MD, MBA, FASRS, FACS
Annual Meeting Talks
2024

Category: AMD-Neovascular

See more